CRKN
Crown Electrokinetics Corp.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$0.00
−80.00%Year over year
Reported trailing growth
- Revenue
- +2580.3%
- EBITDA
- -66.6%
- EBIT
- -60.5%
- EPS
- +100.6%
- Free cash flow
- —
- Operating cash flow
- -88.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- -25.7%
- EBIT
- -25.0%
- Net income
- +10.5%
- EPS
- +99.8%
- Free cash flow
- -32.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2025